Overview of Dr. Ganly
Dr. Ian Ganly is an otolaryngologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Glasgow Faculty of Medicine and has been in practice 28 years. Dr. Ganly accepts several types of health insurance, listed below. He is one of 21 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at NYC Health + Hospitals / Bellevue who specialize in Otolaryngology (ENT). He has more than 100 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
- University of Glasgow Faculty of MedicineClass of 1989
Certifications & Licensure
- NY State Medical License 2006 - 2026
Clinical Trials
- A Single Center Randomized Controlled Trial Assessing Pain and Quality of Life Following Surgery Start of enrollment: 2011 May 01
Publications & Presentations
PubMed
- 11 citationsMinimally Invasive Video-Assisted Thyroidectomy 2.0: Expanded Indications in a Tertiary Care Cancer CenterAlyn J. Kim, Jeffrey C. Liu, Ian Ganly, Dennis H. Kraus
Head & Neck. 2011-11-01 - 78 citationsDNA methylation-based classification of sinonasal undifferentiated carcinoma.Snjezana Dogan, Varshini Vasudevaraja, Bin Xu, Jonathan Serrano, Ryan Ptashkin
Modern Pathology. 2019-06-11 - 68 citationsFrequent IDH2 R172 mutations in undifferentiated and poorly‐differentiated sinonasal carcinomasSnjezana Dogan, Deborah J. Chute, Bin Xu, Ryan Ptashkin, Raghu Chandramohan
The Journal of Pathology. 2017-08-01
Journal Articles
- Multi-Dimensional Genomic Analysis of Myoepithelial Carcinoma Identifies Prevalent Oncogenic Gene FusionsIan Ganly, Alan L Ho, Ronald Ghossein, Nadeem Riaz, Cristina R Antonescu, Nora Katabi, Nature
Press Mentions
- Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell CarcinomaApril 2nd, 2021
- Pretreatment Neutrophil-to-Lymphocyte Ratio and Mutational Burden as Biomarkers of Tumor Response to Immune Checkpoint InhibitorsFebruary 1st, 2021
- Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun BeltJanuary 8th, 2021
- Join now to see all
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Multiplan PHCS PPOMultiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: